Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant.
Visceral leishmaniasis (VL), caused by infection with the obligate intracellular protozoan parasite Leishmania infantum, is a fatal disease of dogs and humans. Protection against VL requires a T helper 1 (Th1) skewed CD4+T response, but despite this knowledge, there are currently no approved-to-market vaccines for humans and only three veterinary-use vaccines globally. As VL progresses from asymptomatic to symptomatic, L. infantum-specific interferon gamma (IFNγ) driven-Th1 responses become dampened and a state of immune exhaustion established. T cell exhaustion and other immunoregulatory processes, starting during asymptomatic disease, are likely to hinder vaccine-induced responses if vaccine is administered to infected, but asymptomatic and seronegative, individuals. In this study we evaluated how immune exhaustion, shown previously by our group to worsen in concert with VL progression, effected the capacity of vaccine candidate antigen/toll-like receptor (TLR) agonist combinations to promote protective CD4+T cell responses during progressive VL. In conjunction with Th1 responses, we also evaluated concomitant stimulation of immune-balanced IL-10 regulatory cytokine production by these vaccine products in progressive VL canine T cells. Vaccine antigen L111f in combination with TLR agonists significantly recovered CD4+T cell IFNγ intracellular production in T cells from asymptomatic VL dogs. Vaccine antigen NS with TLR agonists significantly recovered CD4+T cell production in both endemic control and VL dogs. Combinations of TLR agonists and vaccine antigens overcame L. infantum induced cellular exhaustion, allowing robust Th1 CD4+T cell responses from symptomatic dogs that previously had dampened responses to antigen alone. Antigen-agonist adjuvants can be utilized to promote more robust vaccine responses from infected hosts in endemic areas where vaccination of asymptomatic, L. infantum-infected animals is likely.
Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA 52242, USA; Center for Emerging Infectious Diseases, University of Iowa Research Park, Coralville, IA 52241, USA.
Robert G
RG
Schaut
Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA 52242, USA.
Tara L
TL
Grinnage-Pulley
Department of Veterinary Pathology, College of Veterinary Medicine, Iowa State University, Ames, IA 50011, USA.
Kevin J
KJ
Esch
Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA 52242, USA; Center for Emerging Infectious Diseases, University of Iowa Research Park, Coralville, IA 52241, USA.
Angela J
AJ
Toepp
Infectious Disease Research Institute, Seattle, WA 98102, USA.
Malcolm S
MS
Duthie
Infectious Disease Research Institute, Seattle, WA 98102, USA.
Randall F
RF
Howard
Infectious Disease Research Institute, Seattle, WA 98102, USA.
Steven G
SG
Reed
Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA 52242, USA; Center for Emerging Infectious Diseases, University of Iowa Research Park, Coralville, IA 52241, USA. Electronic address: christine-petersen@uiowa.edu.
Christine A
CA
Petersen
D000276:Adjuvants, Immunologic; D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood; D000953:Antigens, Protozoan / Q000276:immunology*; D058070:Asymptomatic Diseases; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D016207:Cytokines / Q000096:biosynthesis; D004283:Dog Diseases / Q000276:immunology; D004285:Dogs; D007371:Interferon-gamma / Q000096:biosynthesis; D016753:Interleukin-10 / Q000096:biosynthesis; D018314:Leishmania infantum / Q000276:immunology* / Q000302:isolation & purification; D007898:Leishmaniasis, Visceral / Q000276:immunology* / Q000662:veterinary; D016052:Protozoan Vaccines / Q000276:immunology; D051193:Toll-Like Receptors / Q000819:agonists*
D000276:Adjuvants, Immunologic; D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D016207:Cytokines; D016052:Protozoan Vaccines; D051193:Toll-Like Receptors; D016753:Interleukin-10; D007371:Interferon-gamma
Adjuvants; CD4(+) T cells; Cytokines; Leishmania (L.) infantum; Toll-like receptor agonist
PLoS One. 2011 Jan 26;6(1):e16333
21298114
Nat Rev Microbiol. 2011 Jul 11;9(8):604-15
21747391
Vaccine. 2015 Jan 3;33(2):280-8
25475955
Clin Transl Immunology. 2015 Apr 10;4(4):e35
26175894
Vaccine. 2008 Mar 17;26(12):1585-94
18328956
PLoS Negl Trop Dis. 2013 Apr 18;7(4):e2174
23638195
Vaccine. 2008 Mar 25;26(14):1709-24
18295939
Vaccine. 2009 May 11;27(21):2884-90
19428898
PLoS Negl Trop Dis. 2015 Jul 10;9(7):e0003914
26162094
Expert Rev Anti Infect Ther. 2014 Aug;12(8):937-46
24802998
Clin Dermatol. 1996 Sep-Oct;14(5):503-12
8889328
Vaccine. 2004 Jun 2;22(17-18):2234-43
15149782
Vaccine. 2016 May 27;34(25):2779-86
27142329
Vaccine. 2005 Nov 1;23(45):5245-51
16054272
Vaccine. 2011 Apr 27;29(19):3531-7
21414377
Vaccine. 2009 Dec 11;28(2):329-37
19879995
PLoS Negl Trop Dis. 2014 Mar 13;8(3):e2729
24625516
J Infect Dis. 2014 Jan 15;209(2):290-9
23922369
J Immunol. 2016 May 15;196(10):4100-9
27076677
PLoS Negl Trop Dis. 2015 May 08;9(5):e0003751
25955652
Front Immunol. 2012 Jun 11;3:144
22701453
PLoS Pathog. 2013;9(6):e1003476
23825956
J Immunol. 2011 Apr 1;186(7):3977-85
21357266
Nat Immunol. 2002 Feb;3(2):196-200
11812998
Vet Parasitol. 1994 Sep;54(4):367-73
7839561
Vet Res Forum. 2015 Winter;6(1):1-7
25992245
Vaccine. 2010 Oct 28;28(46):7427-35
20851080
Clin Microbiol Infect. 2011 Oct;17(10):1471-7
21933305
Vet Res. 2014 Jun 25;45:69
24964736
Curr Opin Immunol. 2006 Aug;18(4):406-12
16766171
Vaccine. 2007 Aug 14;25(33):6176-90
17630055
PLoS One. 2012;7(5):e35671
22693548
Vaccine. 2012 Jan 5;30(2):134-41
22085553
Vet Parasitol. 2015 Sep 15;212(3-4):130-9
26255093
Vaccine. 2015 Sep 22;33(39):5035-41
26319069
J Am Vet Med Assoc. 2005 Apr 15;226(8):1316-22
15844420
Infect Immun. 2007 Sep;75(9):4648-54
17606603
Clin Vaccine Immunol. 2010 Feb;17(2):267-73
20032217
Antimicrob Agents Chemother. 2001 Aug;45(8):2185-97
11451673
PLoS Negl Trop Dis. 2011 Apr 12;5(4):e1019
21532741
PLoS Negl Trop Dis. 2012;6(2):e1514
22389733
J Immunol. 2010 Aug 1;185(3):1701-10
20601594
J Immunol. 2013 Dec 1;191(11):5542-50
24154626
Am J Trop Med Hyg. 1983 May;32(3):480-4
6407345
PLoS One. 2014 Jan 24;9(1):e86073
24475071
Lancet Infect Dis. 2015 Dec;15(12):1450-8
26342424
J Exp Med. 2007 Apr 16;204(4):805-17
17389235
Vaccine. 2007 Jul 20;25(29):5290-300
17576026
Can Vet J. 2008 Oct;49(10):1005-8
19119370
Nature. 2002 Dec 5;420(6915):502-7
12466842
Clin Vaccine Immunol. 2011 Jul;18(7):1118-24
21632891
Vaccine. 2010 Jan 8;28(3):597-603
19800443
Am J Pathol. 2015 Aug;185(8):2105-17
26079813
Clin Epidemiol. 2014 May 03;6:147-54
24833919
Vaccine. 2010 Apr 26;28(19):3333-40
20206667
J Infect Dis. 2011 Oct 1;204(7):1134-7
21881130
Parasitol Int. 2014 Dec;63(6):826-34
25102355
Emerg Infect Dis. 2006 Mar;12(3):440-6
16704782
Vet Res Commun. 2015 Jun;39(2):87-95
25874857
Front Immunol. 2012 Aug 14;3:251
22912637
Vet Immunol Immunopathol. 2016 Jan;169:34-8
26827836
Parasit Vectors. 2015 Jul 11;8:363
26160291
Lancet Infect Dis. 2011 Feb;11(2):102-9
21237715